drugset / Trial / NCT00658905
Efficacy and Safety of Bile Salt Stimulated Lipase (BSSL) as Replacement Therapy in Infant Formula for Preterm Infants
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy in preterm infants following treatment with BSSL when administered in infant formula.
Timeline
- Start
- 2008-04
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | rhBSSL | Protein / enzyme biologic | 0.15 mg/ml | — |
Indications
No indication recorded.